Therefore, we conducted drug repurposing screens in an FDA-approved anti-cancer drug library (NCI AOD X version) [37] in human cervical cancer HeLa cells and human retinoblastoma Y79 cells, both of which exhibit NR2E3 expression. This evidence concerns the gene NR2E3 and cervical carcinoma.